Sanofi P/E Ratio
Sanofi (SANOFI) P/E ratio is 20.14 (Moderate), EPS (TTM) ₹179.46, current price ₹3388.90 on NSE vs historical average P/E of 30.32 (50.0th percentile) — High - Growth expectations or overvalued. See SANOFI book value comparison to compare market price against book value per share.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
SANOFI P/E Ratio — Valuation Signal & Historical Context
Sanofi P/E 20.14 vs historical average 30.32, range 20.0–40.64 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see SANOFI screener.
- Current PE is 33.6% below historical average
- Trading at discount to sector average PE of 55.83
Sanofi P/E Ratio Historical Trend
SANOFI annual price-to-earnings ratio — 2 years, EPS and year-end price. Current P/E 20.14 vs historical average 30.32. Read SANOFI dividend history for the complete payout history and dividend yield track record.
SANOFI Historical P/E Ratio — EPS, Year-End Price & Valuation
Sanofi annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2024 | 40.64 | 179.45 | ₹7292.15 | NSE | High |
| 2023 | 20.0 | 261.89 | ₹5238.10 | NSE | Moderate |
SANOFI vs Healthcare Peers — P/E Ratio Comparison
Sanofi P/E 20.14 vs Healthcare average 55.83, median 31.44 — range 2.86–916.67.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.61 | ₹64 | Low |
| Sunrest Lifescience | SUNREST | 3.76 | ₹30 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.76 | ₹7,399 | Low |
| Shelter Pharma | SHELTER | 5.23 | ₹47 | Low |
| Dipna Pharmachem | DPL | 5.39 | ₹14 | Low |
| JFL Life Sciences | JFLLIFE | 5.41 | ₹68 | Low |
| Amwill Health Care | AMWILL | 7.26 | ₹83 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹84 | Low |
| Galaxy Medicare | GML | 7.8 | ₹27 | Low |